|
Continued nintedanib (n=212)
n (%)
|
Initiated nintedanib (n=222)
n (%)
|
Diarrhoea | 90 (42.5) | 132 (59.5) |
Nausea | 22 (10.4) | 41 (18.5) |
Vomiting | 15 (7.1) | 31 (14.0) |
Dyspnoea | 25 (11.8) | 17 (7.7) |
Decreased appetite | 13 (6.1) | 26 (11.7) |
Bronchitis | 15 (7.1) | 23 (10.4) |
Alanine aminotransferase increased | 9 (4.2) | 27 (12.2) |
Aspartate aminotransferase increased | 9 (4.2) | 25 (11.3) |
Gamma-glutamyltransferase increased | 3 (1.4) | 23 (10.4) |